ClinicalTrials.gg
CompletedNCT07930845Updated Nov 12, 2026

Continuous vs Intermittent Kangaroo Mother Care and Weight Gain in Low Birth Weight Infants

An interventional study of Continuous Kangaroo Mother Care (KMC) in Low Birthweight Infant and Premature Baby, sponsored by Armed Forces Hospital, Pakistan. Completed at 1 site in Pakistan. Open to participants aged 1 Day to 1 Month. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Armed Forces Hospital, Pakistan · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Dec 2025, registered Oct 2026).
Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
1 Day to 1 Month
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 24 studies in Premature Birth with a site in Pakistan — 4 open to participants now, 5 under way, 1 of them phase 3. Premature Birth · Pakistan.

Enrollment
19th of 20
30 · median 123
Started
2025
with 7 others
No phase
15 of 24
1 open now
Registered
24th of 24
by date
Lead sponsor
1 of 24
Armed Forces Hospital, Pakistan

Among the 24 studies in Premature Birth with a site in Pakistan, this one is the 19th largest by enrollment of the 20 interventional ones that give a count, is one of 8 that started in 2025, is one of 15 with no phase, and was the 24th registered.

Premature Birth

2,553 studies on the registry are indexed under Premature Birth; 502 are open to participants now.

Browse Premature Birth studies →

Open to participants now

4 of the 24 studies in Premature Birth with a site in Pakistan are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 315 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 223 (71%) stop at 75 or younger; 241 take children under 18; 105 take healthy volunteers.

This study: 1 Day to 1 Month · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Premature Birth with a site in Pakistan, or all of them as a file.
02

Study summary

This randomized controlled trial compared the effects of continuous versus intermittent kangaroo mother care (KMC) on weight gain in low birth weight neonates weighing less than 2,000 g admitted to the NICU at Pakistan Emirates Military Hospital, Rawalpindi, from December 2025 to February 2026. A total of 59 neonates were randomized to continuous KMC (n=30) or intermittent KMC (n=29). The primary outcome was weight gain. Continuous KMC was associated with significantly greater weight gain than intermittent KMC (341 ± 123 g vs. 142 ± 89.6 g; p

03

Conditions studied

  • Low Birthweight Infant
  • Premature Baby

Browse trials for

04

Who can participate

Ages eligible
1 Day to 1 Month
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Neonates of either gender
  • Birth weight less than 2,000 grams
  • Alive mothers

Exclusion criteria

Exclusion Criteria:

  • Neonates with congenital defects
  • Neonates born to mothers with gestational diabetes mellitus
  • Neonates born to mothers with pre-eclampsia
  • Neonates born to mothers with eclampsia
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Continuous Kangaroo Mother Care (KMC)

    Behavioral: Continuous Kangaroo Mother Care (KMC)

  • Active comparator
    Intermittent Kangaroo Mother Care (KMC)

    Repeated periods of skin-to-skin contact between the mother and neonate, interrupted by approximately 6 hours of separation per day.

    Behavioral: Continuous Kangaroo Mother Care (KMC)

Interventions

  • BehavioralContinuous Kangaroo Mother Care (KMC)

    Continuous skin-to-skin contact between the mother and neonate during day and night, with minimal separation, defined in this study as at least 12 hours per day.

06

What researchers measure

Primary outcomes

  1. Weight gain in low birth weight neonates

    Weight gain in low birth weight neonates

    Time frame: From initiation of KMC until hospital discharge (approximately 15-20 days of life).

Secondary outcomes

  1. Duration of KMC

    Time frame: From initiation of KMC until hospital discharge (approximately 15-20 days of life).

  2. Duration of hospital stay

    Time frame: From initiation of KMC until hospital discharge (approximately 15-20 days of life).

07

Study locations

1 site
  • PEMH
    Rawalpindi, Pakistan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Feb 2026, 2 months.

Of 744 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 2 months is below that.

Counting every sponsor, half of 762 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 31, 2026
First posted
Nov 12, 2026
StartActual
Dec 1, 2025
Primary completionActual
Feb 28, 2026
CompletionActual
Feb 28, 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07930845
Lead sponsor
Armed Forces Hospital, Pakistan
Responsible party
arshad khushdil (Professor, Armed Forces Hospital, Pakistan) — Principal investigator
First posted
Nov 12, 2026
Start date
Dec 1, 2025
Primary completion
Feb 28, 2026
Completion
Feb 28, 2026
Last update
Nov 12, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion